Comparative Risk-Benefit Assessment of Drugs Used in the Management of Hypertension in Pregnancy
- 1 January 1992
- journal article
- research article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 7 (3), 223-234
- https://doi.org/10.2165/00002018-199207030-00007
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Effect of Nifedipine on Fetal Heart Rate in the Treatment of Severe Pregnancy-Induced HypertensionAmerican Journal of Perinatology, 1990
- Effect of nifedipine on Doppler flow velocity waveforms in severe pre-eclampsia.BMJ, 1989
- Treatment of hypertension in pregnancy with methyldopa: A randomized double blind studyInternational Journal of Gynecology & Obstetrics, 1987
- The effects of nifedipine, a calcium antagonist, on platelet functionAmerican Heart Journal, 1983
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982
- Beta-Blockers in PregnancyNew England Journal of Medicine, 1981
- β-Adrenoceptor Antagonists: New Drugs and New IndicationsNew England Journal of Medicine, 1981
- Alpha-Adrenergic Receptor SubtypesNew England Journal of Medicine, 1980
- NEONATAL HEAD CIRCUMFERENCE AND THE TREATMENT OF MATERNAL HYPERTENSIONBJOG: An International Journal of Obstetrics and Gynaecology, 1978
- Propranolol administration during pregnancy: Effects on the fetusThe Journal of Pediatrics, 1975